Bing Cui

9.0k total citations · 1 hit paper
122 papers, 4.4k citations indexed

About

Bing Cui is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bing Cui has authored 122 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 33 papers in Immunology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bing Cui's work include Chronic Lymphocytic Leukemia Research (18 papers), Galectins and Cancer Biology (12 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Bing Cui is often cited by papers focused on Chronic Lymphocytic Leukemia Research (18 papers), Galectins and Cancer Biology (12 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Bing Cui collaborates with scholars based in China, United States and United Kingdom. Bing Cui's co-authors include Thomas J. Kipps, Liguang Chen, Suping Zhang, Fang Hua, George F. Widhopf, Zhuowei Hu, Jiaojiao Yu, Xiaoxi Lv, Xiaowei Zhang and Jinmei Yu and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Bing Cui

117 papers receiving 4.4k citations

Hit Papers

Trimethylamine N-oxide impairs β-cell function and glucos... 2024 2026 2025 2024 10 20 30 40
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Trimethylamine N-oxide impairs β-cell function and glucose tolerance
    2024 44 citations Lijuan Kong, Xiaojing Jiang et al. Nature Communications profile →

Peers

Bing Cui
Benjamin D. Hopkins United States
Adam S. Asch United States
Latifa Bakiri Austria
Ann Zeuner Italy
Didier Bouscary France
Bo Zhai China
Keiji Shimada Japan
Rishu Takimoto Japan
Gong Yang China
Itaru Matsumura Japan
Benjamin D. Hopkins United States
Bing Cui
Citations per year, relative to Bing Cui Bing Cui (= 1×) peers Benjamin D. Hopkins

Countries citing papers authored by Bing Cui

Since Specialization
Citations

This map shows the geographic impact of Bing Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Cui more than expected).

Fields of papers citing papers by Bing Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Cui. The network helps show where Bing Cui may publish in the future.

Co-authorship network of co-authors of Bing Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Cui. A scholar is included among the top collaborators of Bing Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Cui. Bing Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yibing, Qian Jiang, Xiaowei Xing, et al.. (2025). Macrophage Derived Galectin‐3 Promotes Renal Fibrosis and Diabetic Kidney Disease by Enhancing TGFβ1 Signaling. Advanced Science. 12(35). e04032–e04032. 3 indexed citations
2.
Kong, Lijuan, Xiaojing Jiang, Qian Jiang, et al.. (2024). Trimethylamine N-oxide impairs β-cell function and glucose tolerance. Nature Communications. 15(1). 2526–2526. 44 indexed citations breakdown →
3.
Chen, Yibing, Chunxiao Ma, Xiaohong Peng, et al.. (2024). Galectin-3 impairs calcium transients and β-cell function. Nature Communications. 15(1). 3682–3682. 15 indexed citations
4.
Hou, Shaocong, Andrew M. Johnson, Xingfeng Liu, et al.. (2024). Intestinal epithelial cell NCoR deficiency ameliorates obesity and metabolic syndrome. Acta Pharmaceutica Sinica B. 14(12). 5267–5285.
5.
Wang, Feng, Yunxuan Li, Zhao-na Yang, et al.. (2024). Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia. Nature Communications. 15(1). 203–203. 8 indexed citations
6.
Yu, Liang, Mengchen Xu, Yupeng Yan, et al.. (2023). ZFYVE28 mediates insulin resistance by promoting phosphorylated insulin receptor degradation via increasing late endosomes production. Nature Communications. 14(1). 6833–6833. 6 indexed citations
7.
Zhang, Cheng, Jiaojiao Yu, Chen Yang, et al.. (2023). Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway. Science Translational Medicine. 15(726). eade4113–eade4113. 13 indexed citations
8.
Chen, Yú, Jian Li, ‪Shuyuan Zhang, et al.. (2022). Genetic risk of hyperuricemia in hypertensive patients associated with antihypertensive drug therapy: A longitudinal study. Clinical Genetics. 101(4). 411–420. 5 indexed citations
9.
Xiao, Xiao, Rui Li, Cunjin Wu, et al.. (2022). A genome-wide association study identifies a novel association between SDC3 and apparent treatment-resistant hypertension. BMC Medicine. 20(1). 463–463. 3 indexed citations
10.
Yang, Fang, Haiqing Liao, Shugang Hu, et al.. (2022). Variation in Spectral Characteristics of Dissolved Organic Matter and Its Relationship with Phytoplankton of Eutrophic Shallow Lakes in Spring and Summer. Water. 14(19). 2999–2999. 4 indexed citations
11.
Liu, Xingfeng, Kai Wang, Luhai Wang, et al.. (2022). Hepatocyte leukotriene B4 receptor 1 promotes NAFLD development in obesity. Hepatology. 78(2). 562–577. 26 indexed citations
12.
Liu, Xingfeng, Kai Wang, Shaocong Hou, et al.. (2022). Insulin induces insulin receptor degradation in the liver through EphB4. Nature Metabolism. 4(9). 1202–1213. 21 indexed citations
13.
Shang, Shuang, Liang Yu, Ke Li, et al.. (2022). TRIB3 reduces CD8 + T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer. Science Translational Medicine. 14(626). eabf0992–eabf0992. 100 indexed citations
14.
Yan, Yupeng, Jine Wang, Liang Yu, et al.. (2021). ANKRD36 Is Involved in Hypertension by Altering Expression of ENaC Genes. Circulation Research. 129(11). 1067–1081. 12 indexed citations
15.
He, Mingli, Bing Cui, Jine Wang, et al.. (2021). Focus on blood pressure levels and variability in the early phase of acute ischemic stroke with hypertension and carotid stenosis. Journal of Clinical Hypertension. 23(12). 2089–2099. 2 indexed citations
16.
17.
He, Mingli, Bing Cui, Cunjin Wu, et al.. (2018). Blood pressures immediately following ischemic strokes are associated with cerebral perfusion and neurologic function. Journal of Clinical Hypertension. 20(6). 1008–1015. 6 indexed citations
18.
Cui, Bing & Jinmei Yu. (2017). Autophagy: a new pathway for traditional Chinese medicine. Journal of Asian Natural Products Research. 20(1). 14–26. 14 indexed citations
19.
20.
Cui, Bing, Suping Zhang, Liguang Chen, et al.. (2013). Targeting ROR1 Inhibits Epithelial–Mesenchymal Transition and Metastasis. Cancer Research. 73(12). 3649–3660. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin D. Hopkins Breakdown of academic impact, for papers by Adam S. Asch Breakdown of academic impact, for papers by Latifa Bakiri Breakdown of academic impact, for papers by Ann Zeuner Breakdown of academic impact, for papers by Didier Bouscary Breakdown of academic impact, for papers by Bo Zhai Breakdown of academic impact, for papers by Keiji Shimada Breakdown of academic impact, for papers by Rishu Takimoto Breakdown of academic impact, for papers by Gong Yang Breakdown of academic impact, for papers by Itaru Matsumura
Rankless by CCL
2026